Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells
Abstract Background The requirement of the Mek1 inhibitor (iMek1) during naïve pluripotency maintenance results from the activation of the Mek1-Erk1/2 (Mek/Erk) signaling pathway upon leukemia inhibitory factor (LIF) stimulation. Methods Through a meta-analysis of previous genome-wide screening for...
Main Authors: | Seong-Min Kim, Eun-Ji Kwon, Yun-Jeong Kim, Young-Hyun Go, Ji-Young Oh, Seokwoo Park, Jeong Tae Do, Keun-Tae Kim, Hyuk-Jin Cha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-022-02976-z |
Similar Items
-
SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling
by: Charlène Niogret, et al.
Published: (2019-10-01) -
Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds
by: Wenjie Guo, et al.
Published: (2020-11-01) -
Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
by: Matthew T.N. Yarnall, et al.
Published: (2022-12-01) -
Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency
by: Hyun Woo Choi, et al.
Published: (2016-11-01) -
Shp1 in Solid Cancers and Their Therapy
by: Alessia Varone, et al.
Published: (2020-06-01)